Updated remission duration and survival results of single-agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia (AML) unlikely to benefit from standard induction chemotherapy due to unfavorable baseline risk factor (s)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Erba, HP; Kantarjian, HM; Claxton, DF; Arellano, M; Lyons, RM; Kovacsovics, TJ; Gabrilove, J; Eckert, S; Faderl, S

Published Date

  • May 20, 2009

Published In

Volume / Issue

  • 27 / 15

Published By


  • 2

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 45th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Orlando, FL

Conference Start Date

  • May 29, 2009

Conference End Date

  • June 2, 2009